RXO, Inc.
RXO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,421,000 | $1,419,000 | $1,433,000 | $1,667,000 |
| % Growth | 0.1% | -1% | -14% | – |
| Cost of Goods Sold | $1,185,000 | $1,165,000 | $1,201,000 | $1,407,000 |
| Gross Profit | $236,000 | $254,000 | $232,000 | $260,000 |
| % Margin | 16.6% | 17.9% | 16.2% | 15.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $243,000 | $214,000 | $262,000 | $284,000 |
| Operating Expenses | $243,000 | $214,000 | $262,000 | $284,000 |
| Operating Income | -$7,000 | $40,000 | -$30,000 | -$24,000 |
| % Margin | -0.5% | 2.8% | -2.1% | -1.4% |
| Other Income/Exp. Net | -$8,000 | -$50,000 | -$9,000 | -$9,000 |
| Pre-Tax Income | -$15,000 | -$10,000 | -$39,000 | -$33,000 |
| Tax Expense | -$1,000 | -$1,000 | -$8,000 | -$8,000 |
| Net Income | -$14,000 | -$9,000 | -$31,000 | -$25,000 |
| % Margin | -1% | -0.6% | -2.2% | -1.5% |
| EPS | -0.08 | -0.053 | -0.18 | -0.12 |
| % Growth | -49.8% | 70.3% | -50% | – |
| EPS Diluted | -0.08 | -0.053 | -0.18 | -0.12 |
| Weighted Avg Shares Out | 168,578 | 168,525 | 168,023 | 164,407 |
| Weighted Avg Shares Out Dil | 168,578 | 168,525 | 168,023 | 164,407 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9,000 | $8,000 | $9,000 | $8,000 |
| Depreciation & Amortization | $26,000 | $30,000 | $32,000 | $33,000 |
| EBITDA | $20,000 | $40,000 | $22,000 | $42,000 |
| % Margin | 1.4% | 2.8% | 1.5% | 2.5% |